Labcorp Holdings (LH) is poised for long-term growth through strategic investments in cell and gene therapy, expansion into the consumer market, and international growth. The company faces headwinds from macroeconomic uncertainties and currency fluctuations, but its cost-saving initiatives and strong performance in key areas position it for continued success.